Evotec (OTCMKTS:EVTCY) Stock Price Crosses Above 50-Day Moving Average - What's Next?

Key Points

• Evotec SE shares have crossed above their 50-day moving average of $3.67, reaching a high of $4.00 during trading.
• The company has a market capitalization of $1.29 billion and a PE ratio of 9.56, indicating a potentially undervalued stock.
• Evotec engages in drug discovery and development, operating through two segments: EVT Execute and EVT Innovate.

Evotec SE (OTCMKTS:EVTCY - ) shares crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $3.67 and traded as high as $4.00. Evotec shares last traded at $3.92, with a volume of 22,631 shares changing hands.

Evotec Trading Down 1.8%

The firm has a market capitalization of $1.29 billion, a PE ratio of 9.56 and a beta of 0.98. The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53. The stock's fifty day simple moving average is $3.67 and its 200 day simple moving average is $3.83.

Evotec Company Profile

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.